小児ヘルスケア市場の2030年までの予測：治療タイプ別、薬剤タイプ別、年齢層別、適応症別、用途別、エンドユーザー別、地域別の世界分析

Stratistics MRCによると、世界の小児ヘルスケア市場は2024年に147億米ドルを占め、予測期間中にCAGR 6.4%で成長し、2030年には200億米ドルに達する見込みです。

新生児、幼児、18歳までの青年に医療、治療、予防サービスを提供するのが小児ヘルスケアの専門セグメントです。新生児治療、予防接種、疾病予防、糖尿病、喘息、先天性疾患などの長期的な問題の診断、治療、管理などが含まれます。栄養カウンセリングと予防接種プログラムは、重要な予防介入です。一人ひとりに合ったケアを提供するために、小児科医、看護師、専門家が両親と連携しています。質の高い小児ヘルスケアへの世界のアクセスは、遠隔医療、医療技術、AIによる診断の開発によって向上しています。

2021年12月に発表されたObserver Research Foundationのデータによると、インドには約2億人の栄養不足の人々がいます。感染症は、世界中で5歳以下の子どもの主要死因であり続けています。

慢性疾患の増加

喘息、糖尿病、肥満などの小児の慢性疾患は、継続的な診察と専門的ケアを必要とするため、小児ヘルスケアサービスの需要が高まっています。さらに、慢性疾患の管理には早期診断と早期介入が不可欠であり、先進的診断ツールと治療オプションの必要性がさらに強調されています。子どもの定期健診の重要性に対する保護者の意識の高まりも、市場の成長に寄与しています。

高い治療費と限られた保険適用範囲

慢性疾患や複雑な病状の子どもの専門医療は法外に高額な場合があり、多くの家庭では必要な治療を受ける金銭的余裕がないです。さらに、すべての保険制度が小児ヘルスケアサービスを十分にカバーしているわけではないため、家族の自己負担が大きくなります。治療に伴う経済的負担は、親が子どものために適時適切な治療を受けることを躊躇させています。すべての子どもたちが質の高い医療サービスを受けられるようにするには、保険適用を改善し、治療費を削減する治療が不可欠です。

子どもの健康と栄養に対する意識の高まり

親や養育者は、子どものためにバランスの取れた食事、定期的な運動、予防的医療を行うことの重要性について、知識を深めています。こうした意識の高まりが、健康教育プログラム、栄養カウンセリング、ウェルネスサービスへの需要を後押ししています。学校や地域団体も、子どもたちに健康的なライフスタイルの選択を促す役割を果たしています。その結果、小児ヘルスケアプロバイダーは、子どもの身体的、精神的、情緒的な幸福に取り組む包括的な健康とウェルネスプログラムを含むサービスを拡大しつつあります。

小児科専門医の不足

小児科医、小児科看護師、その他の専門的な医療専門家に対する需要の高まりに、十分な供給が追いついていないです。この不足は、予約待ち時間の長期化、専門的ケアへのアクセス低下、既存の医療提供者の業務負担増につながる可能性があります。小児科専門医の不足は、特に専門的な知識を必要とする複雑な病状の子どもたちに提供されるケアの質にも影響を及ぼし、市場の成長を阻害する可能性があります。

COVID-19の影響

COVID-19パンデミックは小児ヘルスケア市場に大きな影響を与えました。パンデミックは緊急性のない医療処置や定期検診の延期につながり、小児の医療利用全体に影響を与えました。しかし、遠隔診察や遠隔医療サービスのニーズは急増し、戸締まり中の子どもたちにも医療への継続的なアクセスを提供しました。パンデミックはまた、予防接種と子どもの予防医療の重要性に対する認識を高めました。

予測期間中、外科手術セグメントが最大となる見込み

先天異常、外傷、その他外科的介入を必要とする病状に対する小児外科手術の増加により、外科手術セグメントは予測期間中最大の市場シェアを占めると予想されます。低侵襲手術手技の進歩や、小児患者向けの特殊な手術器具が利用できるようになったことが、このセグメントの成長にさらに寄与しています。より良い健康結果を得るための早期外科的介入の重要性に対する意識の高まりも、小児外科手術の需要を支えています。

予測期間中、新生児（0～28日）セグメントのCAGRが最も高くなる見込み

予測期間中、新生児（0～28日）セグメントは、早産率の上昇と新生児健康合併症の増加により、新生児ケアへの注目が高まっているため、最も高い成長率を示すと予測されます。新生児集中治療室（NICU）の進歩や新生児に特化した医療機器の利用可能性が、このセグメントの拡大を支えています。さらに、新生児死亡率の低下と新生児ケアの質の向上を目的とした政府の取り組みやプログラムが、新生児ヘルスケアサービスの需要をさらに押し上げています。

最大のシェアを占める地域

予測期間中、北米地域が最大の市場シェアを占めると予想されるが、これは同地域の確立された医療インフラ、高い医療費、主要な小児ヘルスケアプロバイダーの存在がその支配的地位に貢献しているためです。さらに、小児の慢性疾患の有病率の増加と小児専門医療に対する需要の高まりが、北米の市場成長を後押ししています。小児の健康増進と乳幼児死亡率の低下を目的とした政府の取り組みや施策が、小児ヘルスケアサービスの拡大をさらに後押ししています。

CAGRが最も高い地域

予測期間中、アジア太平洋が最も高いCAGRを示すと予測されます。この地域の小児ヘルスケア市場の急成長は、慢性疾患の有病率の増加、医療費の増加、医療インフラの拡大が要因となっています。中国やインドのような国々がこの成長の最前線にあり、子どもの健康増進と乳幼児死亡率の低下を目指した政府の取り組みが行われています。子どもの予防医療と定期検診の重要性に対する保護者の意識の高まりが、市場拡大をさらに後押ししています。

無料のカスタマイズサービス

本レポートをご購読の顧客には、以下の無料カスタマイズオプションのいずれかをご利用いただけます。

• 企業プロファイル
  • 追加市場参入企業の包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推定・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携による主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査情報源
  • 1次調査情報源
  • 2次調査情報源
  • 前提条件

第3章 市場動向分析

• イントロダクション
• 促進要因
• 抑制要因
• 機会
• 脅威
• 用途分析
• エンドユーザー分析
• 新興市場
• COVID-19の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の小児ヘルスケア市場：治療タイプ別

• イントロダクション
• 薬剤
• 外科手術
• 予防ケア
• 治療
• その他

第6章 世界の小児ヘルスケア市場：薬剤タイプ別

• イントロダクション
• 抗生物質
• 鎮痛剤と痛み止め
• 解熱剤
• 抗アレルギー薬
• 抗炎症薬
• 抗ウイルス薬
• 抗けいれん薬
• 化学療法薬

第7章 世界の小児ヘルスケア市場：年齢層別

• イントロダクション
• 新生児（0～28日）
• 乳児（1ヶ月～1歳）
• 幼児（1～3歳）
• 未就学児（3～5歳）
• 学齢児童（6～12歳）

第8章 世界の小児ヘルスケア市場：適応症別

• イントロダクション
• 喘息とアレルギー
• 心臓疾患
• 遺伝性疾患
• 糖尿病
• 肥満
• その他

第9章 世界の小児ヘルスケア市場：用途別

• イントロダクション
• 小児科専門医療
• 救急・重篤疾患治療
• メンタルヘルスと行動健康
• 在宅医療と遠隔医療
• 病気の治療と管理
• その他

第10章 世界の小児ヘルスケア市場：エンドユーザー別

• イントロダクション
• 病院
• クリニックと外来診療センター
• 研究・学術機関
• 政府と非政府組織
• その他

第11章 世界の小児ヘルスケア市場：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他の欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他のアジア太平洋
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他の南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他の中東・アフリカ

第12章 主要開発

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品発売
• 事業拡大
• その他の主要戦略

第13章 企業プロファイリング

• Abbott Laboratories
• BAYADA Home Health Care
• Boehringer Ingelheim International GmbH
• BrightStar Care
• Eisai Co.
• Eli Lilly and Company
• EnViva Paediatric Care
• Gilead Sciences
• GlaxosmithklinePlc
• Johnson & Johnson
• Novartis International AG
• Pfizer Inc
• Sanofi S A
• Tendercare Home Health
• The Procter & Gamble Company
• Viatris

List of Tables

• Table 1 Global Paediatric Healthcare Market Outlook, By Region (2022-2030) ($MN)
• Table 2 Global Paediatric Healthcare Market Outlook, By Treatment Type (2022-2030) ($MN)
• Table 3 Global Paediatric Healthcare Market Outlook, By Medications (2022-2030) ($MN)
• Table 4 Global Paediatric Healthcare Market Outlook, By Surgical Procedures (2022-2030) ($MN)
• Table 5 Global Paediatric Healthcare Market Outlook, By Preventive Care (2022-2030) ($MN)
• Table 6 Global Paediatric Healthcare Market Outlook, By Therapy (2022-2030) ($MN)
• Table 7 Global Paediatric Healthcare Market Outlook, By Other Treatment Types (2022-2030) ($MN)
• Table 8 Global Paediatric Healthcare Market Outlook, By Drug Type (2022-2030) ($MN)
• Table 9 Global Paediatric Healthcare Market Outlook, By Antibiotics (2022-2030) ($MN)
• Table 10 Global Paediatric Healthcare Market Outlook, By Analgesics and Pain Medications (2022-2030) ($MN)
• Table 11 Global Paediatric Healthcare Market Outlook, By Antipyretics (2022-2030) ($MN)
• Table 12 Global Paediatric Healthcare Market Outlook, By Antiallergy Drugs (2022-2030) ($MN)
• Table 13 Global Paediatric Healthcare Market Outlook, By Anti-inflammatory Drugs (2022-2030) ($MN)
• Table 14 Global Paediatric Healthcare Market Outlook, By Antiviral Drugs (2022-2030) ($MN)
• Table 15 Global Paediatric Healthcare Market Outlook, By Anticonvulsants (2022-2030) ($MN)
• Table 16 Global Paediatric Healthcare Market Outlook, By Chemotherapy Drugs (2022-2030) ($MN)
• Table 17 Global Paediatric Healthcare Market Outlook, By Age Group (2022-2030) ($MN)
• Table 18 Global Paediatric Healthcare Market Outlook, By Neonates (0-28 days) (2022-2030) ($MN)
• Table 19 Global Paediatric Healthcare Market Outlook, By Infants (1 month - 1 year) (2022-2030) ($MN)
• Table 20 Global Paediatric Healthcare Market Outlook, By Toddlers (1-3 years) (2022-2030) ($MN)
• Table 21 Global Paediatric Healthcare Market Outlook, By Preschoolers (3-5 years) (2022-2030) ($MN)
• Table 22 Global Paediatric Healthcare Market Outlook, By School-aged Children (6-12 years) (2022-2030) ($MN)
• Table 23 Global Paediatric Healthcare Market Outlook, By Indication (2022-2030) ($MN)
• Table 24 Global Paediatric Healthcare Market Outlook, By Asthma & Allergies (2022-2030) ($MN)
• Table 25 Global Paediatric Healthcare Market Outlook, By Cardiac Disorders (2022-2030) ($MN)
• Table 26 Global Paediatric Healthcare Market Outlook, By Genetic Disorders (2022-2030) ($MN)
• Table 27 Global Paediatric Healthcare Market Outlook, By Diabetes (2022-2030) ($MN)
• Table 28 Global Paediatric Healthcare Market Outlook, By Obesity (2022-2030) ($MN)
• Table 29 Global Paediatric Healthcare Market Outlook, By Other Indications (2022-2030) ($MN)
• Table 30 Global Paediatric Healthcare Market Outlook, By Application (2022-2030) ($MN)
• Table 31 Global Paediatric Healthcare Market Outlook, By Paediatric Specialty Care (2022-2030) ($MN)
• Table 32 Global Paediatric Healthcare Market Outlook, By Emergency & Critical Care (2022-2030) ($MN)
• Table 33 Global Paediatric Healthcare Market Outlook, By Mental & Behavioural Health (2022-2030) ($MN)
• Table 34 Global Paediatric Healthcare Market Outlook, By Home Healthcare & Telemedicine (2022-2030) ($MN)
• Table 35 Global Paediatric Healthcare Market Outlook, By Disease Treatment & Management (2022-2030) ($MN)
• Table 36 Global Paediatric Healthcare Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 37 Global Paediatric Healthcare Market Outlook, By End User (2022-2030) ($MN)
• Table 38 Global Paediatric Healthcare Market Outlook, By Hospitals (2022-2030) ($MN)
• Table 39 Global Paediatric Healthcare Market Outlook, By Clinics & Ambulatory Care Centres (2022-2030) ($MN)
• Table 40 Global Paediatric Healthcare Market Outlook, By Research & Academic Institutions (2022-2030) ($MN)
• Table 41 Global Paediatric Healthcare Market Outlook, By Government & Non-Governmental Organizations (2022-2030) ($MN)
• Table 42 Global Paediatric Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

According to Stratistics MRC, the Global Paediatric Healthcare Market is accounted for $14.7 billion in 2024 and is expected to reach $20.0 billion by 2030 growing at a CAGR of 6.4% during the forecast period. Providing medical care, treatment, and preventative services to newborns, kids, and teenagers up to the age of eighteen is the specialty of pediatric healthcare. Neonatal care, vaccinations, illness prevention, and the diagnosis, treatment, and management of long-term problems such as diabetes, asthma, and congenital disorders are all included. Nutritional counselling and immunization programs are important preventive interventions. To provide individualized care, paediatricians, nurses, and specialists work in tandem with parents. Global access to high-quality pediatric care has been enhanced by developments in telemedicine, medical technology, and AI-driven diagnostics.

According to Observer Research Foundation data published in December 2021, India has nearly 200 million undernourished people. Infectious disorders continue to be the primary causes of death among children under the age of five around the world.

Market Dynamics:

Driver:

Increasing prevalence of chronic illnesses

Chronic illnesses among children, such as asthma, diabetes, and obesity conditions require ongoing medical attention and specialized care, leading to a higher demand for paediatric healthcare services. Additionally, early diagnosis and intervention are critical for managing chronic illnesses, further emphasizing the need for advanced diagnostic tools and treatment options. The growing awareness among parents about the importance of regular health check-ups for their children is also contributing to the market's growth.

Restraint:

High treatment costs & limited insurance coverage

Specialized care for children with chronic illnesses or complex medical conditions can be prohibitively expensive, making it difficult for many families to afford the necessary treatments. Furthermore, not all insurance plans provide adequate coverage for paediatric healthcare services, leading to out-of-pocket expenses for families. The financial burden associated with medical treatments can deter parents from seeking timely and appropriate care for their children. Efforts to improve insurance coverage and reduce treatment costs are essential to ensure that all children have access to quality healthcare services.

Opportunity:

Increased awareness of child health & nutrition

Parents and caregivers are becoming more informed about the importance of a balanced diet, regular exercise, and preventive healthcare for their children. This heightened awareness is driving demand for health education programs, nutritional counselling, and wellness services. Schools and community organizations are also playing a role in promoting healthy lifestyle choices among children. As a result, paediatric healthcare providers are expanding their services to include comprehensive health and wellness programs that address the physical, mental, and emotional well-being of children.

Threat:

Shortage of paediatric specialists

The growing demand for paediatricians, paediatric nurses, and other specialized healthcare professionals is not being met with an adequate supply. This shortage can lead to longer wait times for appointments, reduced access to specialized care, and increased workloads for existing healthcare providers. The lack of paediatric specialists can also impact the quality of care provided to children, particularly those with complex medical conditions requiring specialized expertise impeding the market growth.

Covid-19 Impact

The COVID-19 pandemic has had a profound impact on the paediatric healthcare market. The pandemic led to the postponement of non-urgent medical procedures and routine check-ups, affecting overall healthcare utilization for children. However, the need for remote consultations and telehealth services surged, providing continued access to medical care for children during lockdowns. The pandemic also heightened awareness about the importance of vaccinations and preventive healthcare for children.

The surgical procedures segment is expected to be the largest during the forecast period

The surgical procedures segment is expected to account for the largest market share during the forecast period due to increasing number of paediatric surgeries for congenital anomalies, trauma, and other medical conditions requiring surgical intervention. Advances in minimally invasive surgical techniques and the availability of specialized surgical equipment for paediatric patients further contribute to the segment's growth. The rise in awareness about the importance of early surgical intervention for better health outcomes also supports the demand for paediatric surgical procedures.

The neonates (0-28 days) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the neonates (0-28 days) segment is predicted to witness the highest growth rate owing to increasing focus on neonatal care, driven by rising preterm birth rates and neonatal health complications, is a key factor contributing to this growth. Advances in neonatal intensive care units (NICUs) and the availability of specialized medical equipment for newborns support the segment's expansion. Additionally, government initiatives and programs aimed at reducing neonatal mortality rates and improving the quality of care for newborns further drive the demand for neonatal healthcare services.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to region's well-established healthcare infrastructure, high healthcare expenditure, and the presence of major paediatric healthcare providers contribute to its dominant position. Additionally, the increasing prevalence of chronic illnesses among children and the rising demand for specialized paediatric care drive the market growth in North America. Government initiatives and policies aimed at improving child health and reducing infant mortality rates further support the expansion of paediatric healthcare services.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR attributed rapid growth of the paediatric healthcare market in this region is driven by the increasing prevalence of chronic illnesses, rising healthcare expenditure, and the expansion of healthcare infrastructure. Countries like China and India are at the forefront of this growth, with government initiatives aimed at improving child health and reducing infant mortality rates. The growing awareness among parents about the importance of preventive healthcare and regular check-ups for children further supports the market expansion.

Key players in the market

Some of the key players in Paediatric Healthcare market include Abbott Laboratories, BAYADA Home Health Care, Boehringer Ingelheim International GmbH, BrightStar Care, Eisai Co., Eli Lilly and Company, EnViva Paediatric Care, Gilead Sciences, GlaxosmithklinePlc, Johnson & Johnson, Novartis International AG, Pfizer Inc, Sanofi S A, Tendercare Home Health, The Procter & Gamble Company and Viatris.

Key Developments:

In January 2025, Eli Lilly and Company and Scorpion Therapeutics, Inc announced a definitive agreement for Lilly to acquire Scorpion's PI3Ka inhibitor program STX-478. STX-478 is a once-daily oral, mutant-selective PI3Ka inhibitor currently being evaluated in a Phase 1/2.

In January 2025, Johnson & Johnson and Intra-Cellular Therapies, Inc. announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Intra-Cellular Therapies.

In December 2024, Abbott announced it has reached an agreement with DexCom, Inc. to settle all outstanding patent disputes between the companies in cases related to continuous glucose monitoring products.

Treatment Types Covered:

• Medications
• Surgical Procedures
• Preventive Care
• Therapy
• Other Treatment Types

Drug Types Covered:

• Antibiotics
• Analgesics and Pain Medications
• Antipyretics
• Antiallergy Drugs
• Anti-inflammatory Drugs
• Antiviral Drugs
• Anticonvulsants
• Chemotherapy Drugs

Age Groups Covered:

• Neonates (0-28 days)
• Infants (1 month - 1 year)
• Toddlers (1-3 years)
• Preschoolers (3-5 years)
• School-aged Children (6-12 years)

Indications Covered:

• Asthma & Allergies
• Cardiac Disorders
• Genetic Disorders
• Diabetes
• Obesity
• Other Indications

Applications Covered:

• Paediatric Specialty Care
• Emergency & Critical Care
• Mental & Behavioural Health
• Home Healthcare & Telemedicine
• Disease Treatment & Management
• Other Applications

End Users Covered:

• Hospitals
• Clinics & Ambulatory Care Centres
• Research & Academic Institutions
• Government & Non-Governmental Organizations
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Paediatric Healthcare Market, By Treatment Type

• 5.1 Introduction
• 5.2 Medications
• 5.3 Surgical Procedures
• 5.4 Preventive Care
• 5.5 Therapy
• 5.6 Other Treatment Types

6 Global Paediatric Healthcare Market, By Drug Type

• 6.1 Introduction
• 6.2 Antibiotics
• 6.3 Analgesics and Pain Medications
• 6.4 Antipyretics
• 6.5 Antiallergy Drugs
• 6.6 Anti-inflammatory Drugs
• 6.7 Antiviral Drugs
• 6.8 Anticonvulsants
• 6.9 Chemotherapy Drugs

7 Global Paediatric Healthcare Market, By Age Group

• 7.1 Introduction
• 7.2 Neonates (0-28 days)
• 7.3 Infants (1 month - 1 year)
• 7.4 Toddlers (1-3 years)
• 7.5 Preschoolers (3-5 years)
• 7.6 School-aged Children (6-12 years)

8 Global Paediatric Healthcare Market, By Indication

• 8.1 Introduction
• 8.2 Asthma & Allergies
• 8.3 Cardiac Disorders
• 8.4 Genetic Disorders
• 8.5 Diabetes
• 8.6 Obesity
• 8.7 Other Indications

9 Global Paediatric Healthcare Market, By Application

• 9.1 Introduction
• 9.2 Paediatric Specialty Care
• 9.3 Emergency & Critical Care
• 9.4 Mental & Behavioural Health
• 9.5 Home Healthcare & Telemedicine
• 9.6 Disease Treatment & Management
• 9.7 Other Applications

10 Global Paediatric Healthcare Market, By End User

• 10.1 Introduction
• 10.2 Hospitals
• 10.3 Clinics & Ambulatory Care Centres
• 10.4 Research & Academic Institutions
• 10.5 Government & Non-Governmental Organizations
• 10.6 Other End Users

11 Global Paediatric Healthcare Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 Abbott Laboratories
• 13.2 BAYADA Home Health Care
• 13.3 Boehringer Ingelheim International GmbH
• 13.4 BrightStar Care
• 13.5 Eisai Co.
• 13.6 Eli Lilly and Company
• 13.7 EnViva Paediatric Care
• 13.8 Gilead Sciences
• 13.9 GlaxosmithklinePlc
• 13.10 Johnson & Johnson
• 13.11 Novartis International AG
• 13.12 Pfizer Inc
• 13.13 Sanofi S A
• 13.14 Tendercare Home Health
• 13.15 The Procter & Gamble Company
• 13.16 Viatris